To further understand the impact of BF10 on tumor-infiltrated immune cells, single-cell RNA-seq (scRNA-seq) was performed in murine orthotopic HNSCC tumors treated with IL-10-Fc, αCSF1R, BF10, or a control IgG. The gene discussed is IL10; the disease is head and neck squamous cell carcinoma.